PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $130,000 | -77.7% | 12,047 | -19.9% | 0.12% | -64.1% |
| Q1 2019 | $583,000 | +48.3% | 15,031 | -22.1% | 0.33% | +58.2% |
| Q4 2018 | $393,000 | -28.9% | 19,288 | +59.9% | 0.21% | -13.7% |
| Q3 2018 | $553,000 | +65.1% | 12,063 | +330.8% | 0.24% | +153.7% |
| Q3 2017 | $335,000 | +47.6% | 2,800 | +7.7% | 0.10% | +21.8% |
| Q2 2017 | $227,000 | -65.3% | 2,600 | -87.8% | 0.08% | -77.3% |
| Q4 2016 | $654,000 | +69.9% | 21,300 | +62.6% | 0.34% | +33.9% |
| Q1 2016 | $385,000 | – | 13,100 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |